ATE412673T1

Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 11 June 2021, 5.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

21 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
21124700United States of AmericaP

Members21

Family members, oldest first
DocumentOfficeKind
UY26763A1UruguayA1
CA2411919A1CanadaA1
WO0196379A2World Intellectual Property Organization (WIPO)A2
US2002044928A1United States of AmericaA1
WO0196379A3World Intellectual Property Organization (WIPO)A3
EP1294771A2European Patent Office (EPO)A2
AR028713A1ArgentinaA1
US6660270B2United States of AmericaB2
US2004062774A1United States of AmericaA1
US6875853B2United States of AmericaB2
US2005142615A1United States of AmericaA1
US7258992B2United States of AmericaB2
US2008009022A1United States of AmericaA1
EP1294771B1European Patent Office (EPO)B1
AT412673TAustriaT
ATE412673T1This recordAustriaT1
DE60136356D1GermanyD1
DK1294771T3DenmarkT3
PT1294771EPortugalE
ES2316450T3SpainT3
CA2411919CCanadaC